How Should We Classify Kawasaki Disease?

被引:49
作者
Marrani, Edoardo [1 ]
Burns, Jane C. [2 ]
Cimaz, Rolando [1 ]
机构
[1] Univ Florence, Meyer Childrens Hosp, Dept Neurosci Psychol Drug Res & Child Hlth, Rheumatol Unit, Florence, Italy
[2] Univ Calif San Diego, Dept Pediat, Kawasaki Dis Res Ctr, Rady Childrens Hosp, San Diego, CA 92103 USA
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
关键词
Kawasaki disease; etiopathogenesis; pediatric vasculitis; intravenous immune globulin (IVIg); coronary aneurysm; ANTIENDOTHELIAL CELL ANTIBODIES; MOUSE MODEL; VASCULITIS; ANAKINRA; CLASSIFICATION; AUTOANTIBODIES; BLOCKADE; RECEPTOR; CHILD;
D O I
10.3389/fimmu.2018.02974
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The exact classification of Kawasaki disease (KD) has been debated. Infectious disease specialists have claimed it as an infection with a classic immune responses to an as yet unidentified pathogen that localizes to the coronary arteries. Others have favored an autoreactive hypothesis that KD is triggered by an antigen that shares homology with structures in the vascular wall, and molecular mimicry resulting in an immune response directed to that tissue. Rheumatologists have classified it as a systemic vasculitis, while some immunologists have stressed the robust nature of the innate immune response that causes both systemic inflammation as well as damage to the coronary arterial wall and questioned whether KD falls within the spectrum of autoinflammatory diseases. This review will describe the evidences available up to now regarding these hypotheses.
引用
收藏
页数:7
相关论文
共 66 条
[1]   Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease [J].
Bar-Meir, Maskit ;
Kalisky, Itai ;
Schwartz, Andrei ;
Somekh, Eli ;
Tasher, Diana .
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (01) :25-29
[2]  
Blonz G, 2018, JCR-J CLIN RHEUMATOL, DOI [10.1097/RHU.0000000000000814, DOI 10.1097/RHU.0000000000000814.[]
[3]   Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin [J].
Burns, J. C. ;
Song, Y. ;
Bujold, M. ;
Shimizu, C. ;
Kanegaye, J. T. ;
Tremoulet, A. H. ;
Franco, A. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2013, 174 (03) :337-344
[4]   International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease [J].
Burns, Jane C. ;
Kone-Paut, Isabelle ;
Kuijpers, Taco ;
Shimizu, Chisato ;
Tremoulet, Adriana ;
Arditi, Moshe .
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) :268-276
[5]   Kawasaki syndrome [J].
Burns, JC ;
Glodé, MP .
LANCET, 2004, 364 (9433) :533-544
[6]   A Case of Vitiligo after Kawasaki's Disease [J].
Cho, Han Kyoung ;
Eun, Lucy Youngmin ;
Song, Ji-Sun ;
Kang, Won Hyoung ;
Ro, Byung In .
ANNALS OF DERMATOLOGY, 2009, 21 (01) :75-77
[7]   A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation [J].
Cohen, Sophie ;
Tacke, Carline E. ;
Straver, Bart ;
Meijer, Natasja ;
Kuipers, Irene M. ;
Kuijpers, Taco W. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (12) :2059-U183
[8]  
Cunningham MW, 1999, J IMMUNOL, V163, P1060
[9]  
DOSSANTOS D, 2018, BMJ OPEN, V8, DOI DOI 10.1136/BMJ0PEN-2017-018803
[10]   Specificity of regulatory T cells that modulate vascular inflammation [J].
Franco, Alessandra ;
Touma, Ranim ;
Song, Yali ;
Shimizu, Chisato ;
Tremoulet, Adriana H. ;
Kanegaye, John T. ;
Burns, Jane C. .
AUTOIMMUNITY, 2014, 47 (02) :95-104